In the present study, the clinical records of 70 patients with stage I–IIIA NSCLC were retrospectively evaluated, and it was detected that PI3K and p-Akt expression occurred in the membrane of lung cancer cells, as well as the cytoplasm and occasionally the nucleus. This evidence concerns the gene AKT1 and lung cancer.